Trial Profile
A Single-Dose Study in Healthy Volunteers to Assess the Pharmacokinetic Profile of a New Formulation of BIIB061
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Sep 2015
Price :
$35
*
At a glance
- Drugs BIIB 061 (Primary)
- Indications Multiple sclerosis
- Focus Pharmacokinetics
- Sponsors Biogen
- 04 Sep 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 17 Aug 2015 New trial record